Literature DB >> 12919739

Identification of conformational and cold-sensitive mutations in the MuLV envelope protein.

Lucille O'Reilly1, Monica J Roth.   

Abstract

The structure and function of the C-terminal domain of the murine leukemia virus Surface protein (MuLV SU) is not well defined. Passage of chimeric ecotropic-amphotropic MuLV viruses with junctions within the SU C-terminus results in the selection of specific point mutations which improve virus viability and Env function. Point mutations were characterized that alter the conformation of the SU/TM heterodimers on the viral particles. Mutation of position E311 within the Moloney MuLV SU protein alters the conformation of the TM protein and its recognition by antibody 42-114 in immunoprecipitation reactions. Mutation of either G541R in the amphotropic 4070A TM, V421M in the 4070A SU, or deletion of S39 and P40 at the N-terminus of the M-MuLV SU results in an irreversible cold-sensitive phenotype at 4 degrees C. This loss of viral titer can be restored by incorporating V421M plus G541R or del S39 P40 plus G541R in cis within the SU/TM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919739     DOI: 10.1016/s0042-6822(03)00244-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.

Authors:  Heather H Cheng; Maria M Anderson; F Claire Hankenson; Lily Johnston; Chitra V Kotwaliwale; Julie Overbaugh
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  The MuLV 4070A G541R Env mutation decreases the stability and alters the conformation of the TM ectodomain.

Authors:  William M Schneider; Haiyan Zheng; Marie L Coté; Monica J Roth
Journal:  Virology       Date:  2007-10-24       Impact factor: 3.616

3.  G541R within the 4070A TM protein regulates fusion in murine leukemia viruses.

Authors:  Lucille O'Reilly; Monica J Roth
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.